CLS Holdings (CLSH) Another Million Dollar
Month - $1.15 Price Target by
Canaccord
CLS Holdings (OTCQB: CLSH) just
announced record sales of $1 million for the month of September
alone.
Price target of $1.15 per share
by Canaccord Genuity,
Acquisition Target In Good
Health receives Massachusetts State Approval for Final Recreation
License
Miami, FL-- (InvestorsHub
NewsWire – October 9, 2019) – EmergingGrowth.com, a leading
independent small cap media portal with an extensive history of
providing unparalleled content for the Emerging Growth markets and
companies, reports on CLS Holdings USA, Inc. (OTCQB: CLSH).
This could be the biggest play in the Cannabis space in
years. See the full story on http://www.EmergingGrowth.com
CLSH may not be at these levels much
longer.
See the Press Release and more on CLS Holdings, Inc.
(OTCQB: CLSH) at
EmergingGrowth.com
https://emerginggrowth.com/stock-report/?code=clsh
CLS Holdings (OTCQB: CLSH) (CLSH.CN)
is a best of breed stock that combines all of the best attributes
of cannabis stocks into one company.
CLS Holdings
(OTCQB: CLSH) just announced record sales of $1
million for the month of September alone. – An Increase of
40.3% from the same period 2018.
See the full
press release here.
Highlights from
the PR:
-
Consolidated revenue from Oasis Cannabis and City
Trees of $1.0 million compared to
$0.7 million in September
2018, an increase of
40.3%. Consolidated gross margin of
49.1% compared to 42.1% in September
2018.
-
A 90.8% increase in dispensary customers, from
10,294 (343 per day) in September 2018 to a record 19,637 (654
per day) in September 2019.
CLS Holdings (OTCQB: CLSH) also just received a C $1.50 – USD
$1.15price target from Canaccord Genuity. See their full
report here.
CLS Holdings (OTCQB: CLSH) just announced that In Good
Health, a licensed medical dispensary, which the Company has the
exclusive right to acquire in January 2020, was granted on Friday,
September 13, 2019 a final license for recreational use at its
current location in Brockton, MA.
In Good Health operates a large medical cannabis dispensary
business consisting of over 25,000 registered patients, delivery to
2,800 patients per month and maintains an 18,000 square foot grow
with capacity to produce 9,000 pounds of finished flower per year.
At today’s retail price of $7,000 per pound this fully built out
operation is capable of generating $60 million in annual revenue
and gross profit of $ 35 million.
-
$50
million acquisition which should throw off $20 million in EBITDA
the first year.
-
$10
million in the Bank
-
Strong medical and retail
marijuana franchise in both Massachusetts and
Nevada.
-
With the advent of recreational
sales in in Massachusetts they are at an inflection point where
sales growth is going to compound
higher.
See the full report on CLS
Holdings USA, Inc. on EmergingGrowth.com here.
See more news on CLS Holdings USA, Inc. on
EmergingGrowth.com here.
CLSH’s management team has also fully aggregated one
acquisition know as Oasis Cannabis.
This is one of the top dispensaries n Las Vegas and one glance at
the interior retail space will tell the story with its clean
professional look.
They also have a decent balance sheet with $10 million in
the bank at FYE 19 and the past quarterly reports have showed a
positive trend that looks like they are turning the corner to
profitability. They also have plans to grow their operations
capacity and have a retail brand known as City Trees which is a
specially formulated THC distillate used in vape products,
tinctures, and caplets. This product is gaining traction in
the market and is distributed in 47 dispensaries. They are
vertically integrated and in every way a seed to shelf
company. This means there are so many chances for cross
promotion, which eventually finds its way to the bottom
line.
Many still see huge opportunity in cannabis but the
industry itself has gone through a massive correction in its price
to sales multiples in just the past 6 months. This means
investors are not as ready to pay for sales as they once
were. Leading in the contraction are the top players like
Canopy Growth (NYSE:
CGC), Tilray, Inc. (NASDAQ:
TLRY), and CuraLeaf (OTC
Pink: CURLF) which nearly halved their multiples. The
biggest standout was Cronos Group, Inc. (NASDAQ:
CRON) which went from 255 down to 19. This multiple
contraction means that investors will need to see increasing
revenue growth quarter over quarter to sustain the stock prices of
these companies.
Summary
The cannabis sector clearly looks like it has put in a
double bottom on a technical basis so now could be an opportune
time to step into the sector and buy value. The next stage of
growth could very well be mergers and acquisitions, but it’s
unlikely that the top brands backed by conglomerates will be
creating mega brands. Those businesses like Tilray, Inc.
(NASDAQ:
TLRY), Cronos Group, Inc. (NASDAQ:
CRON), and Canopy Growth (NYSE:
CGC) will start to work when these large brands start selling
and launching CBD or THC infused products. Mergers an
acquisition plays could also begin to happen in the space and
represent big upside for investors.
The sweet spot in the sectors seems to be a company that
can successfully complete acquisitions at fantastic valuations
while increasing their revenues and profitability all at once. CLS
Holdings USA, Inc. (OTCQB: CLSH) is a best of breed stock with all
the characteristics an investor is looking for including a great
price. By all metrics the stock seems extremely undervalued
and ready to run. After the acquisition in 2020 revenues are
expected to be $50 million.
CLSH may not be at these levels much
longer.
See the Press Release and more on CLS Holdings, Inc.
(OTCQB: CLSH) at
EmergingGrowth.com
https://emerginggrowth.com/stock-report/?code=clsh
Other Companies in the news and
featured on EmergingGrowth.com
Kraig Biocraft Laboratories,
Inc.
Kraig Biocraft Laboratories, Inc.
(OTCQB:
KBLB) announced yesterday the Launch of Spider Silk Production
Scale up. The stock took a hard fall from .47 - .17 in
July and has been in consolidation mode ever since despite the
company’s 10 press releases since. Kraig traded 2.1 million
shares yesterday but has resistance at
$.24.
Have a look at CLS Holdings, Inc.
(OTCQB: CLSH) who just released record
numbers. This could be the most undervalued stock in the
cannabis sector. Canaccord Genuity issued a $1.15 price
target.
United Energy
Corp.
Shares of stop sign company
United Energy Corp. (OTC:
UNRG) has traded approximately $55 million dollars’ worth of
stock while moving up 12,000% over the past 28 trading sessions.
There is no news, or filings reported on OTC Markets. The
toping tale from last Thursday indicates that this stock can drop
far and hard, as it has already began to
demonstrate.
CLS Holdings, Inc. (OTCQB: CLSH), a fully reporting QB just hit
record numbers and was issued a $1.15 price target from Canaccord
Genuity.
Clancy Systems International,
Inc.
Shares of another stop sign company Clancy Systems
International, Inc. (OTC:
CLSI) shot up over 1,200% since filing its 8K on Sept. 25, 2019
which stated that they “will be filing its annual and quarterly
reports as a voluntary filer.” A review of its period ending
6/30/19 Quarterly showed cash of $1 million, but no sales to speak
of. CLSI peaked at .12, formed a large daily toping tale and looks
like it can be on its way back down.
Have a look at CLS Holdings, Inc. (OTCQB: CLSH) with its over $1 million per month
in sales and $10 million in the
bank.
About
EmergingGrowth.com
EmergingGrowth.com is a leading
independent small cap media portal with an extensive history of
providing unparalleled content for the Emerging Growth markets and
companies. Through its evolution, EmergingGrowth.com found a niche
in identifying companies that can be overlooked by the markets due
to, among other reasons, trading price or market capitalization. We
look for strong management, innovation, strategy, execution, and
the overall potential for long- term growth. Aside from being a
trusted resource for the Emerging Growth info-seekers, we are well
known for discovering undervalued companies and bringing them to
the attention of the investment community. Through our parent
Company, we also have the ability to facilitate road shows to
present your products and services to the most influential
investment banks in the space.
All information contained herein
as well as on the EmergingGrowth.com website is obtained from
sources believed to be reliable but not guaranteed to be accurate
or all-inclusive. All material is for informational purposes only,
is only the opinion of EmergingGrowth.com and should not be
construed as an offer or solicitation to buy or sell securities.
The information includes certain forward-looking statements, which
may be affected by unforeseen circumstances and / or certain risks.
This report is not without bias. EmergingGrowth.com has
motivation by means of either self-marketing or EmergingGrowth.com
has been compensated by or for a company or companies discussed in
this article. EmergingGrowth.com has been compensated twenty four
thousand dollars in consideration for its work with CLS Holdings
USA, Inc. EmergingGrowth.com may or may not receive additional
compensation and full details about which can be found in our
full disclosure, which can be found
here, https://emerginggrowth.com/2574-68272/ .
You can easily loose money investing in highly speculative small
cap stocks like the ones mentioned within. Please consult an
investment professional before investing in anything viewed within.
When EmergingGrowth.com is long shares it will sell those shares.
In addition, please make sure you read and understand the Terms of
Use, Privacy Policy and the Disclosure posted on the
EmergingGrowth.com website.
CONTACT:
Company: EmergingGrowth.com - http://www.EmergingGrowth.com
Contact Email: info@EmergingGrowth.com
SOURCE: EmergingGrowth.com
